| Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
| c.3603C>A | p.Cys1201X | Heterozygous | Mutation |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| TGC | Cys | TGA | Stop | C->A | Tv |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| cb EGF-like #15 | Disulfide bonds 1201-1212 (C1) | No | No |
| At the mRNA level | On restriction map |
| NA | New restriction site(s): none Lost restriction site(s): none |
| Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
| JAP02TOK F0024 I0001 | Proband | NA | NA | JAPAN |
| Phenotypic group | Disease |
| NA | NA |
| Symptom |
| no clinical data |
| Reference ID | PubMed ID | Reference |
| 229 | 21907952 | Ogawa N, Imai Y, Takahashi Y, Nawata K, Hara K, Nishimura H, Kato M, Takeda N, Kohro T, Morita H, Taketani T, Morota T, Yamazaki T, Goto J, Tsuji S, Takamoto S, Nagai R, Hirata Y. "Evaluating Japanese patients with the Marfan syndrome using high-throughput microarray-based mutational analysis of fibrillin-1 gene". Am J Cardiol. 2011 Dec 15;108(12):1801-7. |